Intellectus Partners, LLC Vertex Pharmaceuticals Inc Transaction History

Intellectus Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$234.96 - $292.55 $20,441 - $25,451	-87 Reduced 2.32%	3,660 $1.03 Million
Q1 2022 May 16, 2022	SELL	$221.42 - $260.97 $38,527 - $45,408	-174 Reduced 4.44%	3,747 $978,000
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $60,714 - $76,643	343 Added 9.59%	3,921 $861,000
Q3 2021 Nov 16, 2021	BUY	$181.39 - $202.99 $72,011 - $80,587	397 Added 12.48%	3,578 $649,000
Q2 2021 Aug 13, 2021	BUY	$187.49 - $221.1 $596,405 - $703,319	3,181 New	3,181 $641,000

1,716

225M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Intellectus Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Intellectus Partners, LLC with notifications on news.